Your browser doesn't support javascript.
loading
The effect of late-onset CMV infection on the outcome of renal allograft considering initial graft function.
Shahmirzadi, Mohammadreza R; Gunaratnam, Lakshman; Jevnikar, Anthony M; Luke, Patrick; House, Andrew A; Silverman, Michael S; Hosseini-Moghaddam, Seyed M.
Afiliação
  • Shahmirzadi MR; Multiorgan Transplant Program, London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Gunaratnam L; Division of Infectious Diseases, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, Toronto, Ontario, Canada.
  • Jevnikar AM; Multiorgan Transplant Program, London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Luke P; Division of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • House AA; Multiorgan Transplant Program, London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Silverman MS; Multiorgan Transplant Program, London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Hosseini-Moghaddam SM; Multiorgan Transplant Program, London Health Sciences Centre, Western University, London, Ontario, Canada.
Transpl Infect Dis ; 25(4): e14081, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37247212
ABSTRACT

BACKGROUND:

Delayed graft function (DGF) increases the renal allograft failure risk. Late-onset Cytomegalovirus (CMV) infection's effect on the association between DGF and allograft failure has not been determined.

METHODS:

In this retrospective cohort, we included all renal allograft recipients at London Health Sciences Centre from January 1, 2014 to December 30, 2017, and continued clinical follow-up until February 28, 2020. We determined whether late-onset CMV infection affects the association between DGF and allograft failure in stratified and Cox proportional hazard analyses.

RESULTS:

Of 384 patients (median age [interquartile range] 55 [43.3-63]; 38.7% female), 57 recipients (14.8%) were diagnosed with DGF. Patients with DGF were at a greater risk of CMV infection than patients without DGF (22.8% vs. 11.3%, p = .017). Late-onset CMV infection (odds ratio [OR] 4.7, 95% CI 2.07-10.68) and rejection (OR 9.59, 95% CI 4.15-22.16) significantly increased the risk of allograft failure in recipients with DGF. Patients with DGF had a significantly greater risk of graft failure than those without DGF (17.5% vs. 6.1%, p = .007). In the adjusted Cox hazard model, CMV infection significantly increased the risk of allograft failure (aHR 3.19, 95% CI 1.49-6.84).

CONCLUSION:

Late-onset CMV infection considerably increased the risk of graft failure in patients with DGF. A hybrid preventive model including prophylaxis followed by CMV-specific cell-mediated immunity monitoring may decrease the risk of allograft failure in recipients with DGF.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Infecções por Citomegalovirus / Insuficiência Renal Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Transpl Infect Dis Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Infecções por Citomegalovirus / Insuficiência Renal Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Transpl Infect Dis Ano de publicação: 2023 Tipo de documento: Article